rs35766971
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000334268.9(TRDN):c.1016G>A(p.Ser339Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,591,380 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S339S) has been classified as Likely benign.
Frequency
Consequence
ENST00000334268.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.1016G>A | p.Ser339Asn | missense_variant | 12/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.1019G>A | p.Ser340Asn | missense_variant | 12/21 | NP_001238916.1 | ||
TRDN | NM_001407315.1 | c.959G>A | p.Ser320Asn | missense_variant | 11/20 | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.1016G>A | p.Ser339Asn | missense_variant | 12/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 | |
TRDN-AS1 | ENST00000587106.6 | n.572-1505C>T | intron_variant, non_coding_transcript_variant | 5 | ||||||
TRDN | ENST00000662930.1 | c.1019G>A | p.Ser340Asn | missense_variant | 12/21 | ENSP00000499585 |
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1734AN: 152068Hom.: 37 Cov.: 32
GnomAD3 exomes AF: 0.00271 AC: 594AN: 219566Hom.: 12 AF XY: 0.00201 AC XY: 239AN XY: 119004
GnomAD4 exome AF: 0.00107 AC: 1534AN: 1439194Hom.: 35 Cov.: 30 AF XY: 0.000887 AC XY: 634AN XY: 714934
GnomAD4 genome AF: 0.0114 AC: 1736AN: 152186Hom.: 37 Cov.: 32 AF XY: 0.0107 AC XY: 793AN XY: 74406
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Ser340Asn in exon 12 of TRDN: This variant is not expected to have clinical sign ificance because it has been identified in 3.3% (123/3682) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs35766971). - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 15, 2024 | - - |
TRDN-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 19, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at